GT Biopharma, Inc. Share Price
NASDAQ: GTBP | Micro CapGT Biopharma, Inc. Stock Performance
GT Biopharma, Inc. Share Price Today
As of 31 October 2026, GT Biopharma, Inc.'s share price is $5.63. The stock opened at $5.63, compared to its previous close of $5.62. During today's trading session, GT Biopharma, Inc.'s share price traded between $5.63 and $5.63, with an average price of $5.63. Over the past 52 weeks, the stock has recorded a high of $11.81 and a low of $0.23. In terms of performance, GT Biopharma, Inc.'s share price has risen by 1714.52% over the last six months and is up 795.70% on a year-on-year basis.
GT Biopharma, Inc. Share Price Chart
GT Biopharma, Inc. Quarterly Profit & Loss
All figures in USD
GT Biopharma, Inc. Annual Profit & Loss
All figures in USD
About GT Biopharma, Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.
GT Biopharma, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $6.35 | $5.63 | -17.46% |
Sep 2026 | $0.28 | $6.82 | +2,171.67% |
Aug 2026 | $0.30 | $0.30 | +2.74% |
Jul 2026 | $0.47 | $0.29 | -40.04% |
Jun 2026 | $0.49 | $0.49 | +1.67% |
May 2026 | $0.34 | $0.48 | +54.52% |
Apr 2026 | $0.41 | $0.31 | -25.48% |
Mar 2026 | $0.45 | $0.42 | -11.30% |
Feb 2026 | $0.65 | $0.47 | -29.26% |
Jan 2026 | $0.79 | $0.66 | -16.08% |
Dec 2025 | $0.77 | $0.79 | +0.00% |
Nov 2025 | $0.64 | $0.79 | +25.80% |